Reuters logo
BRIEF-ACHIEVE LIFE SCIENCES COMMENCES ADVANCEMENT OF CYTISINE CLINICAL DEVELOPMENT PROGRAM
October 4, 2017 / 9:37 AM / in 19 days

BRIEF-ACHIEVE LIFE SCIENCES COMMENCES ADVANCEMENT OF CYTISINE CLINICAL DEVELOPMENT PROGRAM

Oct 4 (Reuters) - Achieve Life Sciences Inc:

* ACHIEVE LIFE SCIENCES INC - ANNOUNCES COMMENCEMENT OF A MULTI-DOSE STUDY TO EVALUATE BOTH PK AND PD CHARACTERISTICS OF CYTISINE

* ACHIEVE LIFE SCIENCES INC - ‍MULTI-DOSE PK/PD STUDY EXPECTED TO BE COMPLETED BY END OF YEAR, WITH DATA EXPECTED BY FIRST-QUARTER OF 2018​

* ACHIEVE LIFE SCIENCES-‍DATA ANALYSIS ONGOING,RESULTS EXPECTED BY END OF YEAR IN STUDY FOR EVALUATING EFFECT OF FOOD ON BIOAVAILABILITY OF 3MG CYTISINE​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below